Status:
COMPLETED
HIV Self-Testing to Empower Prevention Choices in Sex Workers
Lead Sponsor:
Makerere University
Collaborating Sponsors:
University of Washington
Massachusetts General Hospital
Conditions:
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transgender, male, and female sex workers are 49, 21 and 14 times as likely to be HIV-infected as other adults in the general population. In Uganda, sex workers have high HIV seroprevalence (35-37%) a...
Detailed Description
This is a randomized clinical trial of HIV-uninfected transgender, female, and male sex workers. The overall goal is to test if HIV self-testing increases PrEP adherence (Aim 1), changes sexual risk b...
Eligibility Criteria
Inclusion
- Exchanged sex for goods or money at least once in the prior month
- Able and willing to provide written informed consent
- HIV-uninfected based on negative HIV rapid tests according to the national Uganda algorithm
- Adequate renal function (normal creatinine levels; calculated creatinine clearance ≥ 60ml/min)
- Not infected with Hepatitis B virus (negative HBsAg test)
- Not enrolled in HIV prevention trial currently or within the past year
- Not currently using PrEP
- Willing to remain in the study for the next 12 months
- Own a mobile phone for personal use
- Have regular access to electricity for charging a mobile phone
Exclusion
- A physical or mental condition that prohibits informed consent and/or participation in study procedures
Key Trial Info
Start Date :
May 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03426670
Start Date
May 21 2018
End Date
January 31 2020
Last Update
February 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Diseases Institute,Makerere University College of Health Sciences
Kampala, Uganda